The first case of acquired hemophilia A associated with SARS‐CoV‐2 infection
Sign Up to like & getrecommendations! Published in 2020 at "American Journal of Hematology"
DOI: 10.1002/ajh.25865
Abstract: demic this is certainly worth consideration, however, rigorous evidence linking the two remains lacking. The diagnosis of methemoglobinemia is seldom thought of given its rarity, and thus may remain underdiagnosed during the COVID-19 pandemic. The… read more here.
Keywords: case acquired; acquired hemophilia; methylene blue; case ... See more keywords
The tipping point: The critical role of therapeutic apheresis in a case of refractory acquired hemophilia
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Apheresis"
DOI: 10.1002/jca.21509
Abstract: Acquired hemophilia A (AHA) is a rare autoimmune disorder that leads to factor VIII (FVIII) deficiency via autoantibody formation. Standard treatment options include FVIII bypassing factors and immunosuppression. However, the role of therapeutic plasma exchange… read more here.
Keywords: inhibitor; acquired hemophilia; treatment; fviii inhibitor ... See more keywords
Clinical characteristics and outcomes of acquired hemophilia A: experience at a single center in Japan
Sign Up to like & getrecommendations! Published in 2017 at "International Journal of Hematology"
DOI: 10.1007/s12185-017-2210-8
Abstract: Acquired hemophilia A (AHA), which is caused by autoantibodies against coagulation factor VIII (FVIII) is a rare, life-threatening bleeding disorder, the incidence of which appears to be increasing in Japan as the population ages. However,… read more here.
Keywords: acquired hemophilia; outcomes acquired; characteristics outcomes; experience single ... See more keywords
Clinicopathological features of TAFRO syndrome complicated by acquired hemophilia A and development of cardiopulmonary arrest that were successfully treated with VA-ECMO and tocilizumab
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Hematology"
DOI: 10.1007/s12185-019-02604-2
Abstract: TAFRO syndrome and acquired hemophilia A (AHA) are rare, life-threatening diseases; however, the relationship between these two diseases is unknown. A 25-year-old man was transferred to our hospital because of bleeding tendency accompanied by multiple… read more here.
Keywords: features tafro; acquired hemophilia; cardiopulmonary arrest; tafro syndrome ... See more keywords
REFRACTORY HEMORRHAGIC SHOCK SECONDARY TO ACQUIRED HEMOPHILIA A
Sign Up to like & getrecommendations! Published in 2019 at "Chest"
DOI: 10.1016/j.chest.2019.08.1948
Abstract: A week later, she was re-admitted with a syncopal episode. Her hemoglobin was 6.1 g/dL. Computed tomography (CT) showed retroperitoneal (RP) bleeding. She was transferred to our tertiary hospital and was found to be in… read more here.
Keywords: acquired hemophilia; shock secondary; secondary acquired; hemorrhagic shock ... See more keywords
Acquired hemophilia A and other autoimmune diseases after alemtuzumab therapy for multiple sclerosis: A report of two cases.
Sign Up to like & getrecommendations! Published in 2020 at "Multiple sclerosis and related disorders"
DOI: 10.1016/j.msard.2020.102181
Abstract: Alemtuzumab (ALZ) is an anti-CD52 monoclonal antibody used to treat recurrent remittent multiple sclerosis (RRMS). After ALZ infusion, there is a depletion of T and B cells expressing CD52, while the stem cells and innate… read more here.
Keywords: acquired hemophilia; report two; autoimmune diseases; multiple sclerosis ... See more keywords
Hemorrhagic pericardial effusion as the debut of acquired hemophilia in a chronic lymphocytic leukemia patient
Sign Up to like & getrecommendations! Published in 2017 at "Medicine"
DOI: 10.1097/md.0000000000008669
Abstract: Background: Acquired hemophilia A (AHA) is a rare bleeding disease caused by autoantibodies against factor VIII. Spontaneous bleeding symptoms usually affect the skin and muscle, while pericardial effusion is an extremely rare manifestation. In the… read more here.
Keywords: acquired hemophilia; lymphocytic leukemia; chronic lymphocytic; pericardial effusion ... See more keywords
Diagnostic and Treatment Challenges for Acquired Hemophilia A in Pediatrics: Report of 2 Cases
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Pediatric Hematology/Oncology"
DOI: 10.1097/mph.0000000000002007
Abstract: Acquired hemophilia A (AHA) occurs rarely in children. We report 2 cases of adolescent females with AHA. The first case underwent bone marrow aspiration/biopsy during workup, which was complicated by bleeding. Bleeding resolved after initiation… read more here.
Keywords: diagnostic treatment; treatment challenges; treatment; report cases ... See more keywords
Cyclosporine treatment for steroid-resistant nephrosis complicated with acquired hemophilia A: a case report
Sign Up to like & getrecommendations! Published in 2023 at "Annals of Medicine and Surgery"
DOI: 10.1097/ms9.0000000000000353
Abstract: Introduction: Acquired hemophilia refers to the development of a clotting factor deficiency typically, when autoantibodies are produced against coagulation factor and tend to be in the elderly and rare in children. Case report: A 12-year-old… read more here.
Keywords: case report; cyclosporine; treatment; nephrosis ... See more keywords
Activated prothrombin complex concentrate to treat bleeding events in acquired hemophilia A: BAHAS study
Sign Up to like & getrecommendations! Published in 2022 at "European Journal of Haematology"
DOI: 10.1111/ejh.13853
Abstract: Activated prothrombin complex concentrate (aPCC) is a bypassing agent indicated to treat bleeds in patients with acquired hemophilia A (AHA). Nevertheless, its efficacy and safety in the real‐world setting have not often been addressed. read more here.
Keywords: complex concentrate; prothrombin complex; activated prothrombin; acquired hemophilia ... See more keywords
Emicizumab for the treatment of acquired hemophilia A: Retrospective review of a single‐institution experience
Sign Up to like & getrecommendations! Published in 2022 at "Haemophilia"
DOI: 10.1111/hae.14664
Abstract: Acquired haemophilia A (AHA) is a rare and potentially life‐threatening bleeding disorder arising from autoantibodies that inhibit coagulation factor VIII (FVIII). Treatment entails achieving haemostasis with bypassing agents or factor replacement, and eradication of the… read more here.
Keywords: hemophilia retrospective; treatment acquired; retrospective review; emicizumab treatment ... See more keywords